Products

FreeStyle LibreLink App (with LibreView)
Abbott
Endocrinology & Metabolic AI
The FreeStyle LibreLink App allows patients to monitor glucose levels from their smartphone with real-time readings and share data with healthcare professionals via LibreView for review, analysis, and evaluation of historical glucose data.
Abbott LibreView for Healthcare Professionals
Abbott
Endocrinology & Metabolic AI
Abbott LibreView for Healthcare Professionals is a secure, cloud-based diabetes management system that allows healthcare professionals to view, analyze, and share glucose data from Abbott FreeStyle Libre devices for informed treatment decisions and remote patient monitoring.
Merlin.net
Abbott
Cardiology AI
Abbott's Merlin.net Patient Care Network (PCN) is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.

See all 3 products →

About Abbott

Abbott is a global healthcare leader with a rich history spanning over 135 years, dedicated to helping people live healthier and fuller lives. The company operates across a broad and diversified portfolio, encompassing medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. For physicians, Abbott offers a wide array of solutions, from advanced cardiovascular and neuromodulation devices to comprehensive diagnostic systems and tests, including point-of-care and rapid diagnostics. Their nutritional segment provides products like infant formula and adult nutritionals, while their established pharmaceutical products address various therapeutic areas, particularly in emerging markets.

In recent years, Abbott has significantly accelerated its integration of artificial intelligence (AI) across its operations and product offerings. The company leverages AI to enhance diagnostic tools, power connected medical devices, and improve enterprise systems. Examples include algorithmic AI in FreeStyle Libre for glucose monitoring, predictive algorithms in diagnostics for instrument maintenance, imaging AI in Ultreon software for optimal stent placement, and AI-powered systems like Assert-IQ for more accurate atrial fibrillation classification. Abbott is committed to a responsible AI approach, guided by principles of trust, fairness, safety, and transparency, aiming to improve access to care, optimize clinical research, and enhance patient outcomes.

Focus Areas

Diagnostics Medical Devices Nutritionals Branded Generic Medicines Cardiovascular Health Diabetes Management Neuromodulation AI in Imaging Predictive Analytics Continuous Glucose Monitoring Digital Health Oncology Diagnostics

Business Intelligence

PartnershipsiCardio.ai (AI algorithms for electrophysiology imaging), DreaMed Diabetes (integration of FreeStyle Libre data into endo.digital platform), Gan.AI (personalized videos for doctor engagement), Flatiron Health (integrating precision oncology portfolio)
AcquisitionsExact Sciences (March 2026, $21B), Bigfoot Biomedical (Sep 2023), Cardiovascular Systems (Feb 2023), Walk Vascular (Sep 2021), Cephea Valve Technologies (Jan 2019), St. Jude Medical (2017, $25B), Alere (2016, $5.3B), Veropharm (Dec 2014), Topera, Inc (Oct 2014), OptiMedica (Jul 2013), IDEV Technologies (Jul 2013), Solvay Pharmaceuticals (2010, $6.2B), STARLIMS (2010, $123M), Advanced Medical Optics (2009, $1.4B), Kos Pharmaceuticals (2007, $3.7B), Guidant (vascular device division) (2006), TheraSense (2004), Knoll (2001, $6.9B)
TechnologyCloud-native, edge computing, AI operating system, secure AI environment across platforms, AI-driven metabolic coaching (Lingo), algorithmic AI for glucose understanding (FreeStyle Libre), predictive algorithms in core diagnostics, imaging AI (Ultreon software), AI for atrial fibrillation classification (Assert-IQ), generative AI for meal insights (Libre Assist), machine learning models for quality-risk prediction.
FDA Clearances4+ cleared products (estimated)

Products by Abbott

3 products in the directory

FreeStyle LibreLink App (with LibreView)
Abbott
Endocrinology & Metabolic AI
The FreeStyle LibreLink App allows patients to monitor glucose levels from their smartphone with real-time readings and share data with healthcare professionals via LibreView for review, analysis, and evaluation of historical glucose data.
Abbott LibreView for Healthcare Professionals
Abbott
Endocrinology & Metabolic AI
Abbott LibreView for Healthcare Professionals is a secure, cloud-based diabetes management system that allows healthcare professionals to view, analyze, and share glucose data from Abbott FreeStyle Libre devices for informed treatment decisions and remote patient monitoring.
Merlin.net
Abbott
Cardiology AI
Abbott's Merlin.net Patient Care Network (PCN) is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.

What the Web Says

Abbott is a global healthcare company with a mixed reputation among employees and customers. While some employees praise the company's financial benefits, opportunities for growth, and talented colleagues, many report a toxic work culture, micromanagement, poor work-life balance, and frequent layoffs. Product reviews, particularly for their FreeStyle Libre glucose monitoring systems, indicate significant dissatisfaction with product quality, accuracy, and customer service.

Overall: Mixed

Strengths

  • Good pay and benefits
  • Opportunities for learning and career growth
  • Talented and competent colleagues
  • Impactful work in healthcare
  • Well-defined structure in some divisions
  • Supportive team environment in some areas

Limitations

  • Toxic company culture
  • Poor work-life balance and long hours
  • Micromanagement and lack of trust in employees
  • Frequent layoffs and high turnover
  • Substandard product quality and customer service for some products
  • Bureaucracy and internal politics

Based on reviews from: Reddit, G2, Indeed.com, Comparably, Trustpilot, The HIPAA Journal

Last updated: 2026-07-20

Videos

News, demos, and interviews about Abbott.

Loading videos...

Videos load interactively. If none appear, search YouTube for Abbott →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Abbott is integrating AI and predictive analytics into its diagnostic platforms, including oncology and imaging, to enhance accuracy, accelerate results, and provide predictive insights for personalized patient management. This includes leveraging algorithms and multianalyte assays with algorithmic analysis (MAAAs) to improve risk prediction accuracy in oncology. Recently, Abbott acquired Exact Sciences and integrated its precision oncology portfolio into Flatiron Health's OncoEMR platform, enabling clinicians to digitally order tests and receive results within their existing workflow, thereby reducing administrative burden and accelerating treatment decisions.
Abbott's FreeStyle Libre portfolio, a leading sensor-based glucose monitoring system, continues to evolve with enhanced accuracy and user-friendly features. These systems integrate with digital health platforms like the FreeStyle LibreLink app and LibreView cloud-based system, providing comprehensive glucose data and actionable insights for remote monitoring and physician-led treatment decisions. Abbott is also partnering to integrate FreeStyle Libre technology with smart insulin pens and pumps for more automated insulin delivery systems.
Abbott maintains a robust pipeline in cardiovascular and neuromodulation devices, focusing on minimally invasive solutions and advanced therapies such as the AVEIR DR leadless pacemaker and innovative heart valve therapies. In neuromodulation, products like the NeuroSphere Virtual Clinic enable remote programming and patient-physician interaction for chronic pain and movement disorders. Abbott prioritizes extensive clinical support and long-term device reliability through rigorous testing and post-market surveillance to ensure optimal patient outcomes.
Abbott adheres to stringent global regulatory standards for all its products through a comprehensive Ethics and Compliance Program, aligning with laws, regulations, and industry guidelines like AdvaMed. The company invests significantly in quality assurance and compliance, ensuring truthful product communications consistent with approved labels and scientific evidence. Abbott offers extensive support, including clinical education, technical service, and dedicated account management, to ensure optimal product utilization and physician confidence.
Abbott aims for competitive and transparent pricing across its branded generic medicines and nutritional portfolios, particularly in emerging markets where it focuses its branded generics business. The company seeks to establish value-based partnerships that align with healthcare cost containment goals by demonstrating the clinical and economic benefits of its products. Abbott innovates beyond the molecule for differentiated medicines, leveraging local insights and strategic partnerships to provide high-quality, trusted products.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.